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Case Report Rapport de cas
Early experience with continuous positive airway pressure (CPAP) in 
5 horses — A case series
Paul D. MacFarlane, Martina Mosing
Abstract — This case series is the first report of the use of CPAP (continuous positive airway pressure) ventilation 
in adult horses. Two horses and 3 ponies anesthetized for orthopedic procedures in lateral recumbency received 
10 cm H2O CPAP. During anesthesia, arterial oxygen partial pressure tended to increase and arterial carbon dioxide 
pressure tended to increase despite increased minute ventilation index. The measured cardiovascular parameters 
were within physiologic limits.
Résumé — Première expérience avec une ventilation spontanée en pression positive continue (VSPPC) chez 
5 chevaux – série de cas. Cette série de cas est le premier rapport sur l’utilisation de la ventilation spontanée en 
pression positive continue (VSPPC) chez les chevaux adultes. Deux chevaux et 3 poneys anesthésiés pour des 
interventions orthopédiques en décubitus latéral ont reçu une VSPPC de 10 cm H2O. Durant l’anesthésie, la 
pression partielle de l’oxygène dans le sang artériel a eu tendance à augmenter et la pression du gaz carbonique 
dans le sang artériel a eu tendance à augmenter malgré un indice de débit volume-accru. Les paramètres 
cardiovasculaires mesurés se situaient dans les limites physiologiques.
(Traduit par Isabelle Vallières)
Can Vet J 2012;53:426–429
Hypoxemia is a common complication of equine anesthesia (1,2). Whilst a number of processes probably contribute 
to the development of hypoxemia in the anesthetized horse, it 
appears that a decrease in functional residual capacity (FRC) 
(3) and the rapid development of atelectasis in dependent lung 
units, along with a subsequent increase in shunt fraction, play 
a major role (4–6).
Continuous positive airway pressure (CPAP) is a ventilatory 
mode commonly employed in human critical care settings (7). 
The patient is allowed to breathe spontaneously with airway 
pressure held above atmospheric pressure during both inspiration 
and expiration, resulting in increased FRC and alveolar recruit-
ment (7). It differs from spontaneous breathing and spontaneous 
positive end expiratory pressure (sPEEP) insofar that, during 
CPAP, airway pressure never drops below atmospheric pressure 
(Figure 1). In humans CPAP is as effective as intermittent positive 
pressure ventilation (IPPV) in combination with positive end-
expiratory pressure (PEEP) in the treatment of hypoxemia second-
ary to pulmonary shunting, but with less marked cardiovascular 
side effects due to a lower mean airway pressure (8) (Figure 1).
This case series is the first report on the use of CPAP during 
anesthesia in adult horses and ponies in lateral recumbency and 
provides preliminary information upon which future prospective 
studies could be based.
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Figure 1. Changes in airway pressure for spontaneous 
ventilation (SV), spontaneous ventilation with positive end 
expiratory pressure (sPEEP), intermittent positive pressure 
ventilation in combination with PEEP (IPPV 1 PEEP) and 
continuous positive airway pressure (CPAP): CPAP — the 
ventilator attempts to maintain a constant airway pressure, small 
falls occur during inspiration and small rises may occur during 
expiration; SV — during inspiration airway pressure falls below 
zero and it rises above zero during expiration; sPEEP — the end 
expiratory pressure is fixed but during inspiration large falls in 
airway pressure may occur, often to sub-atmospheric levels; 
IPPV 1 PEEP — during inspiration airway pressure is forced to 
rise and then it falls back to the set PEEP level during expiration.
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Case description
Five adult horses were anesthetized for a variety of orthopedic 
procedures, which required the horses to be positioned in right 
lateral recumbency. Cardiovascular or respiratory abnormalities 
were absent on the pre-anesthetic clinical examination. Pre-
anesthetic medication, the use of loco-regional techniques 
and induction agent varied (Table 1). Once connected to a 
large animal anesthetic machine CPAP of 10 cmH2O was 
applied (Tafonius; Vetronic Services, Abbotskerswell, Devon, 
UK). Anesthesia was maintained with halothane (Halothane-
vet; Mérial Animal Health, Harlow, UK) delivered in oxygen 
100% with a fresh gas flow of 4 L/min. An arterial catheter was 
placed into a facial artery for monitoring of arterial pressure 
and collection of blood samples. Heart rate, arterial systolic, 
diastolic and mean pressures (SAP, DAP, MAP), end-tidal halo-
thane concentration, end-tidal CO2, expiratory tidal volume, 
respiratory rate, and minimal and maximal airway pressures 
were continuously monitored using multiparameter monitors 
(Tafonius and Datex-Ohmeda S5; Datex-Ohmeda Finland OY, 
Helsinki, Finland) and recorded every 5 min. It was intended to 
record inspiratory oxygen fraction (FiO2) but due to technical 
problems this was not possible. All horses received Hartmanns 
solution (Vetivex 11; Dechra, Shrewsbury, UK) at approximately 
10 mL/kg body weight (BW) per hour throughout anesthesia. If 
MAP was below 60 mmHg, dobutamine (Dobutamine; Hameln 
Pharmaceuticals, Gloucester, UK) was administered as an infu-
sion intravenously to effect and the total amount recorded. 
Results of arterial blood gas analysis and associated data are 
given in Table 2. Selected average cardiovascular, respiratory, 
and anesthetic information is summarized in Table 3.
Clinical findings
Mean anesthesia time was 98 min (range: 60 to 150 min) 
(Table 1) and all horses recovered uneventfully after surgery.
The arterial oxygen tension (PaO2) increased in all horses 
from the first to the second blood gas analysis except in CASE 2, 
where it decreased from 578 mmHg to 566 mmHg within 
30 min. In all cases the second and any subsequent blood gas 
analysis showed PaO2 to be in excess of 514 mmHg (Table 2).
Arterial carbon dioxide tension (PaCO2) tended to increase 
over the course of anesthesia (Table 2). In CASE 3, PaCO2 was 
74 mmHg after 75 min of anesthesia and IPPV was imposed, 
resulting in a PaCO2 of 64 mmHg after 95 min of anesthesia.
The minute volume index (MVi = minute volume/kg BW) 
increased during anesthesia in all horses except in CASE 2, in 
which it fell (Table 2). This fall was associated with a decreased 
respiratory rate and increased end-tidal halothane tension.
During the application of CPAP, mean peak airway pressure was 
between 11.3 and 12.5 cmH2O and minimum airway  pressure was 
Table 1. Details of anesthetic regimen for horses receiving continuous positive pressure (CPAP) ventilation
 Age    Weight   Other Anesthetic
Case (y) Breed Procedure (kg) Pre-medication Induction medication duration (min)
1  8 Pony Splint bone removal 375 ARM KD Extradural F  60
2 13 New Forest Pony Annular ligament desmotomy 457 ARM KG F  80
3 15 Warmblood Tenoscopy 500 ADM KG F 150
4  6 Welsh section B Splint bone removal 321 ARM KD F  75
5  4 Cob Investigate penetrating wound 578 ARM KD PBZ Abaxial 125
ARM — A (ACP 0.03 mg/kg), R (Romifidine 0.05 to 0.06 mg/kg), M (Morphine 0.1 to 0.2 mg/kg), D (Detomidine 0.01 mg/kg); KD — (Ketamine 2.2 mg/kg and 
Diazepam 0.05 mg/kg); KG — [Ketamine 2.2 mg/kg and guaifenesine (given to effect)]; Extradural — (extradural analgesia: pre-operative extradural morphine 0.08 mg/kg 
and xylazine 0.16 mg/kg); Abaxial — (Abaxial sesamoid block, 4 ml bupivacaine 0.5%); F — (flunixin 1.1 mg/kg); PBZ — (Phenylbutazone 2.2 mg/kg).
Table 2. Changes in arterial oxygen (PaO2) and carbon dioxide (PaCO2) tension with time, along with minute volume 
index (MVi), respiratory rate (Rf ), tidal volume (VT), mean arterial pressure (MBP) and dobutamine infusion rate (Dob), 
and end-tidal halothane (PEHal) concentration during application of 10 cm H2O CPAP (continuous positive airway 
pressure)
 Time from       
 induction PaO2
 PaCO2 MVi Rf VT MBP Dob
Case (min) mmHg mmHg L/kg/min breaths/min L mmHg mg/kg/min PEHal (%)
1 10 491 68 0.048  5 3.6 64 0 0.8
1 40 514 70 0.054  7 2.9 70 1.3 0.7
       
2 31 578 63 0.068  8 3.9 65 0 0.7
2 61 566 74 0.036  4 4.1 60 0 0.9
       
3 15 495 57 0.083  7 5.9 62 0 0.65
3 45 566 65 0.078 10 3.9 72 1.0 0.77
3 75 518 74 0.080 11 3.6 70 1.0 1.3
       
4 15 386 56 0.039  4 3.1 nr 0.39 1.1
4 55 543 64 0.065  8 2.6 70 0.65 1.0
4 65 537 68 0.072  7 3.3 65 0.79 0.88
       
5 23 369 55 0.058  7 4.8 65 0 0.98
5 65 525 65 0.064  8 4.6 74 0.64 1.1
5 97 549 62 0.065 12 3.1 70 0 1.0
nr — no result.
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between 6.8 and 7.9 cmH2O. The lowest airway  pressure recorded 
at any time in any horse was 4 cmH2O (Table 3).
Four of the horses required dobutamine administration to 
maintain MAP above 60 mmHg. The mean dobutamine infu-
sion rate during CPAP in those horses ranged from 0.29 to 
0.75 mg/kg BW per minute (Table 2).
Discussion
This is the first report on the use of CPAP in healthy horses. 
Only 1 recent case report on the use of CPAP at a level of 
20 cmH2O in a horse with diaphragmatic hernia can be found 
in the veterinary literature (9). Besides having 25 L of blood and 
the entire stomach in the thoracic cavity at postmortem, PaO2 
values increased from 66 to 400 mmHg during anesthesia in 
this horse. However, severe hypotension was observed. Within 
some minutes after the horse was disconnected from the CPAP 
ventilator; it died after cardiopulmonary arrest.
A large number of ventilatory modes have been investigated 
in equine anesthesia, ranging from spontaneous ventilation (SV), 
spontaneous ventilation with positive end expiratory pressure 
(sPEEP) (10), IPPV (11), IPPV combined with PEEP (12), 
and differential ventilation of the lungs (5,6). Despite this, the 
2 most widespread modes of ventilation remain SV and IPPV. 
While spontaneous ventilation preserves cardiac function, PaO2 
levels are higher with IPPV during halothane anesthesia (13,14). 
Continuous positive airway pressure increases functional residual 
capacity and can recruit collapsed lung units leading to a 
reduction in intrapulmonary shunt volume in humans (15). 
Cardiovascular compromise with CPAP is less compared with 
IPPV due to lower mean airway pressure (8,16).
We decided to use a CPAP level of 10 cmH2O in the 5 horses 
as this value lies in the middle of the most common range of 
5 to 15 cmH2O in humans to treat refractory hypoxemia, caused 
by intrapulmonary shunting (16). The PaO2 level in the 5 horses 
was satisfactory and the cardiovascular compromises were clini-
cally acceptable. However, as with other ventilatory strategies, 
it is likely that there will be individual variation in the response 
to a given level of CPAP (6).
In order to keep airway pressure as constant as possible and 
especially positive during inspiration, CPAP devices must be able 
to match the high flow rates generated during early inspiration 
and early expiration. This is particularly challenging in the horse 
in which peak inspiratory and expiratory flows may be up to 
4 L/s (17). The piston-driven ventilator used herein has recently 
become available for clinical use in equine anesthesia. Airway 
pressure measured at the y-piece of the breathing circuit controls 
the movement of the piston. In these horses, the response time 
of the system was sufficient to provide CPAP levels $ 4 cmH2O 
in all horses (Table 3).
The PaO2 measured in our horses using CPAP was high 
compared with levels reported in the literature during SV and 
IPPV (4–6,11–14,18). The fact that application of CPAP was 
associated with PaO2 levels $ 518 mmHg 1 h after induction 
in the horses described here could suggest that the formation of 
atelectasis, which is thought to be the main reason for hypox-
emia in healthy horses, can be prevented by the application of 
CPAP (4). It has been shown that ponies defined by body weight 
(203 to 357 kg) have a higher PaO2 level than large horses due 
to their lower body mass (17). Although 3 out of the 5 cases 
were pony breeds, none of the cases had a body weight less than 
300 kg and only the horse in CASE 4 would have been classified 
as a pony in the aforementioned study (321 kg BW).
The partial pressure of carbon dioxide in the cases described 
herein was greater than that found in some previous reports 
(4,5,11,12,19), and tended to increase during anesthesia. In 
CASE 3, the PaCO2 was sufficiently great to warrant the 
imposition of IPPV, resulting in a fall in PaCO2. An increase in 
PaCO2 has been reported when CPAP of 20 cmH2O has been 
used in humans (8). In CASE 2, the rise in PaCO2 was paral-
leled by a fall in MVi and this would be expected as ventilation 
and PaCO2 are typically inversely proportional. Very likely this 
was due to a deeper level of anesthesia at the time of the second 
blood gas sampling, as suggested by the elevated end-tidal halo-
thane tension and decreased respiratory rate (Table 2). However 
in the other 4 cases minute volume appeared to increase in 
parallel to PaCO2 over time (Table 2). The most likely explana-
tion for this increase in PaCO2 is a shift of lung units towards 
a higher V/Q ratio by CPAP, causing alveolar distension or 
decreased perfusion (or both) to specific lung units by decreasing 
cardiac output as a result of increased thoracic pressure. This 
may lead to an increase in alveolar dead space ventilation leading 
to carbon dioxide retention.
Table 3. Mean (6 standard deviation) values for respiratory, cardiovascular, and anesthetic 
parameters during application of 10 cmH2O CPAP (continuous positive airway pressure)
   Rf
 PAP MAP breaths/ VT MBP Dob PEHal
Case (maximum) (minimum) min L mmHg mg/kg/min (%)
1 11.4 (1.4) 7.9 (0.6) 7 (1) 3.3 (0.5) 61 (2) 0.73 (0.69) 0.76 (0.16)
 [13] [6]
2 12.6 (1.2) 7.2 (1.0) 7 (2) 3.8 (0.4) 67 (5) 0 0.68 (0.16)
 [20] [5]
3 12.5 (1.0) 6.8 (1.0) 9 (3) 4.7 (1.1) 72 (6) 0.75 (0.44) 0.78 (0.16)
 [17] [4]
4 11.4 (0.8) 8.0 (0.8) 6 (1) 3.5 (0.8) 72 (4) 0.45 (0.28) 0.86 (0.16)
 [14] [6]
5 12.5 (1.2) 7.2 (1.0) 9 (3) 4.6 (0.9) 73 (6) 0.29 (0.33) 0.99 (0.18)
 [20] [5]
PAP — peak airway pressure, MAP — minimal airway pressure in cmH2O, Rf — respiratory rate in breaths/min, VT — tidal 
volume in L, MBP — mean arterial pressure in mmHg, Dob — dobutamine infusion rate in mg/kg/min, PEHal — end-tidal 
halothane concentration.
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Cardiovascular compromise with CPAP is less compared 
with IPPV due to lower mean airway pressure (8,16). In this 
case series, 4 horses required the administration of dobutamine 
to keep the blood pressure within clinically acceptable limits. 
The rate of dobutamine infusion required to improve arterial 
pressure was lower in all 5 horses compared with previously 
reported doses of 1.5 to 3.2 mg/kg BW per minute in horses 
under halothane anesthesia using SV or IPPV (or both) with a 
wide range of clinical conditions and posture during anesthesia 
compared with the 0.29 to 0.75 mg/kg BW per minute used in 
our 5 cases (20). This could be taken to suggest that the car-
diovascular effect of CPAP at 10 cmH2O was not excessive in 
the 5 horses described here. Dobutamine infusion rate is a very 
crude measure of cardiovascular performance in horses, only 
relating to MAP. In humans it has been reported that MAP may 
be well-maintained when CPAP is imposed, despite reductions 
in cardiac index, potentially leading to a reduction in tissue 
oxygen delivery (21). Severe hypotension was also reported in 
the case of diaphragmatic hernia when a CPAP of 20 cmH2O 
was used (9). Halothane was selected for maintenance of 
anesthesia in our cases as is our common clinical practice. The 
concentration of halothane delivered varied from horse to horse 
as clinically indicated (Tables 2 and 3) and this may have lead to 
differing impacts on the cardiovascular system. As a consequence 
the precise impact of CPAP on the cardiovascular system using 
different anesthetic protocols needs to be further investigated.
The anesthetic protocols, time of blood gas sampling, and 
duration of anesthesia were not standardized in the 5 horses 
as we did not intend to compare the cases or undertake a pro-
spective clinical study, but to collect individual information on 
CPAP and retrospectively analyze the data. This case series sug-
gests that CPAP may improve oxygenation whilst having limited 
deleterious effects on cardiovascular function. This supports the 
need to perform controlled studies of CPAP in horses. These 
studies should attempt to define the degree and mechanism of 
CPAP’s effect on respiratory gas exchange, V/Q mismatch and 
intrapulmonary shunt, and clarify the cardiovascular impact of 
the technique, when varying levels of CPAP are applied, with 
horses in lateral and dorsal recumbency and with alternate 
anesthetic technique.
In conclusion, a CPAP level of 10 cmH2O in healthy horses 
anesthetized in lateral recumbency may be associated with high 
PaO2 and no decrease in ventilatory drive, but elevated PaCO2. 
 CVJ
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